Athira Pharma, Inc.
ATHA
$0.295
-$0.008-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.14M | -15.00M | -28.74M | -26.86M | -26.34M |
| Total Depreciation and Amortization | 243.00K | 243.00K | 243.00K | 242.00K | 242.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.64M | 2.27M | 2.94M | 3.10M | 2.48M |
| Change in Net Operating Assets | -7.40M | -13.52M | 2.53M | 1.19M | -2.19M |
| Cash from Operations | -14.67M | -26.01M | -23.02M | -22.33M | -25.80M |
| Capital Expenditure | -- | 0.00 | 0.00 | -28.00K | -5.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.35M | -2.81M | 18.04M | 26.59M | 13.05M |
| Cash from Investing | -7.35M | -2.81M | 18.04M | 26.56M | 13.04M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 34.00K | 12.00K | 148.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 34.00K | 12.00K | 148.00K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.02M | -28.79M | -4.97M | 4.38M | -12.76M |